As of the latest SEC filings, Immunocore Holdings plc (IMCR) is held by 73 institutional funds. The largest fund shareholder is VANGUARD HEALTH CARE FUND (VGHAX), holding an estimated $118,513,507.34 in market value, representing 0.32% of its portfolio.
Funds holding Immunocore Holdings plc (IMCR)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- IMCR
- CIK:
- 0001671927
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VGHAX
VANGUARD HEALTH CARE FUND
|
MF | Vanguard | 0.32% | $118,513,507.34 | 4,246,274 | Apr 30, 2026 | Jun 26, 2026 |
|
VHCAX
VANGUARD CAPITAL OPPORTUNITY FUND
|
MF | Vanguard | 0.30% | $73,133,347.50 | 2,425,650 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.05% | $38,107,281.60 | 1,179,792 | Feb 28, 2026 | Apr 24, 2026 |
|
POAGX
PRIMECAP Odyssey Aggressive Growth Fund
|
MF | Independent / Boutique | 0.46% | $31,058,248.00 | 1,112,800 | Apr 30, 2026 | Jun 29, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.18% | $19,397,545.20 | 643,368 | Mar 31, 2026 | May 28, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 0.26% | $16,150,000.00 | 500,000 | Feb 28, 2026 | Apr 24, 2026 |
|
OTCFX
T. Rowe Price Small-Cap Stock Fund, Inc.
|
MF | T. Rowe Price | 0.17% | $14,020,654.50 | 465,030 | Mar 31, 2026 | May 28, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.05% | $11,346,537.80 | 351,286 | Feb 28, 2026 | Apr 24, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.19% | $10,384,450.00 | 321,500 | Feb 28, 2026 | Apr 24, 2026 |
|
MNDBX
MFS New Discovery Fund
|
MF | Independent / Boutique | 0.47% | $9,828,728.50 | 304,295 | Feb 28, 2026 | Apr 24, 2026 |
|
BMEZ
BlackRock Health Sciences Term Trust
|
CEF | BlackRock / iShares | 0.96% | $9,705,285.00 | 321,900 | Mar 31, 2026 | May 28, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.04% | $9,401,561.00 | 291,070 | Feb 28, 2026 | Apr 24, 2026 |
|
PASVX
T. Rowe Price Small-Cap Value Fund, Inc.
|
MF | T. Rowe Price | 0.10% | $8,932,962.60 | 296,284 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.10% | $8,357,127.75 | 277,185 | Mar 31, 2026 | May 28, 2026 |
|
TRSSX
T. Rowe Price Institutional Small-Cap Stock Fund
|
MF | T. Rowe Price | 0.18% | $7,975,278.00 | 264,520 | Mar 31, 2026 | May 28, 2026 |
|
FACTX
Fidelity Advisor Health Care Fund
|
MF | Fidelity | 0.25% | $7,256,600.00 | 260,000 | Apr 30, 2026 | Jun 26, 2026 |
|
PSBMX
SmallCap Fund
|
MF | Independent / Boutique | 0.30% | $6,341,152.00 | 227,200 | Apr 30, 2026 | Jun 25, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.09% | $6,094,719.30 | 188,691 | Feb 27, 2026 | Apr 24, 2026 |
|
FDCAX
Fidelity Capital Appreciation Fund
|
MF | Fidelity | 0.06% | $4,434,899.00 | 158,900 | Apr 30, 2026 | Jun 26, 2026 |
|
-
MFS New Discovery Series
|
ETF | Independent / Boutique | 0.43% | $3,075,782.40 | 102,016 | Mar 31, 2026 | May 26, 2026 |
|
HGHIX
THE HARTFORD HEALTHCARE FUND
|
MF | Independent / Boutique | 0.42% | $3,032,923.88 | 108,668 | Apr 30, 2026 | Jun 25, 2026 |
|
-
VIP Health Care Portfolio
|
ETF | Independent / Boutique | 0.25% | $2,532,600.00 | 84,000 | Mar 31, 2026 | May 26, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 0.18% | $2,017,517.40 | 66,916 | Mar 31, 2026 | May 29, 2026 |
|
SPDW
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF
|
ETF | State Street (SPDR) | 0.01% | $1,923,750.90 | 63,806 | Mar 31, 2026 | May 28, 2026 |
|
HSGFX
HUSSMAN STRATEGIC MARKET CYCLE FUND
|
MF | Independent / Boutique | 0.46% | $1,809,000.00 | 60,000 | Mar 31, 2026 | May 29, 2026 |
Advertisement (320x50)